Cytokinetics Inc. buy The Goldman Sachs Group, Inc.
Start price
02.03.23
/
50%
€38.80
Target price
02.03.24
€45.28
Performance (%)
71.39%
End price
03.03.24
€66.50
Summary
This prediction ended on 03.03.24 with a price of €66.50. With a performance of 71.39% the BUY prediction by The_Goldman_Sachs_Gr was a big success. The_Goldman_Sachs_Gr has a follow-up prediction for Cytokinetics Inc. where he still thinks Cytokinetics Inc. is a Buy. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Cytokinetics Inc. | 4.854% | 4.854% | 82.432% |
iShares Core DAX® | 0.039% | 0.567% | 12.281% |
iShares Nasdaq 100 | -4.018% | -5.554% | 23.851% |
iShares Nikkei 225® | -2.389% | -1.434% | 8.335% |
iShares S&P 500 | -2.115% | -2.351% | 22.061% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $56.00 to $48.00. They now have a "buy" rating on the stock.
Ratings data for CYTK provided by MarketBeat
In the thread Trading Cytokinetics Inc.
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten
Current prediction by The_Goldman_Sachs_Gr for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€31.60
09.11.23
09.11.23
€46.68
09.11.24
09.11.24
70.89%
25.07.24
25.07.24